VaccineDanmark.dk ApS: Financial statements 2024
CVR: 42460699
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
VaccineDanmark.dk ApS (CVR 42460699) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -50,390 and a net result of DKK -185,176 compared with DKK -272,101 the year before. Equity in the 2024 report amounted to DKK -126,386.
- Gross Profit
- DKK -50,390
- Profit/Loss
- DKK -185,176
- Equity
- DKK -126,386
- Total Assets
- DKK 215,148
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -50K | -185K | -126K | 0 |
| 2023 | - | -193K | -272K | 5.8M | 0 |
| 2022 | - | 11.5M | 6M | 6M | 29 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of November 11, 2024, AROS STATSAUTORISEREDE REVISORER I/S has stepped down as auditor of VaccineDanmark.dk ApS.
About VaccineDanmark.dk ApS
VaccineDanmark.dk ApS is a Danish company of the type Anpartsselskab based in Herning, founded in 2021. The company is registered under the industry Speciallægers aktiviteter. The management consists of Damir Drljevic. The company is owned by DRDAM ApS. The company has 9 employees (2022). In 2025, the company reported a gross profit of DKK -21,698 and a net result of DKK -26,385 compared with DKK -185,176 the year before. Equity in the 2025 report amounted to DKK -152,771.